Trending Now
CRISPR Therapeutics (NASDAQ:CRSP) and Vertex (NASDAQ:VRTX) Receive Priority Medicines (PRIME) Designation...
CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have announced that the European Medicines Agency has granted their experimental, autologous, ex vivo CRISPR/Cas9 gene-edited...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Novavax Inc. (NASDAQ: NVAX) Receives Positive Market Reaction Amidst Proxy Campaign...
Novavax Inc. (NASDAQ: NVAX) saw a notable increase in its stock price, closing at $15.70, up by 5.30% as of May 22,...
MAKE IT MODERN
LATEST REVIEWS
ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief...
ObsEva SA (NASDA: OBSV) has announced plans to commence corporate restructuring and refocus its commercial and development strategy.
FDA points to shortfalls in ObSeva’s linzagolix...
MAKE IT MODERN
PERFORMANCE TRAINING
Why B2Digital Inc (OTCMKTS:BTDG) is a Game Changer for the Gym Space
The pandemic has been a tragedy. But, according to Chinese linguistic written symbolism, crisis and opportunity are two sides of the same...
The Sustainability Trade Heads for Wall Street Dominance (MASN, FSLR, CSIQ, SPWR, TSLA, BE)
Wall Street is increasingly beholden to the values and ideals of “the new kids on the investing block” as the Millennials and...
Trevena Inc (NASDAQ: TRVN) and Jiangsu Nhwa Pharmaceutical Pronounce the Enrollment of the First...
Trevena Inc (NASDAQ: TRVN) revealed some crucial details regarding its collaboration with its China partner called Jiangsu Nhwa Pharmaceutical. Its partner has successfully enrolled its...
JetBlue (NASDAQ: JBLU)Announces Commitment to Keep Its Headquarters in New York
JetBlue (NASDAQ: JBLU) has announced today that it will retain its headquarters in New York while also moving forward with plans to expand its...
Silverback Therapeutics Inc. (NASDAQ: SBTX) Reports Phase 1/1b SBT6050 Study Data In Combination With...
Silverback Therapeutics Inc. (NASDAQ: SBTX) has presented interim results from its Phase1/1b SBT6050 clinical study as a monotherapy and combined with pembrolizumab in metastatic...
























































